Hypertrophic Cardiomyopathy.
Journal
Journal of cardiovascular development and disease
ISSN: 2308-3425
Titre abrégé: J Cardiovasc Dev Dis
Pays: Switzerland
ID NLM: 101651414
Informations de publication
Date de publication:
02 Mar 2023
02 Mar 2023
Historique:
received:
10
01
2023
revised:
16
01
2023
accepted:
30
01
2023
medline:
29
3
2023
entrez:
28
3
2023
pubmed:
29
3
2023
Statut:
epublish
Résumé
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy resulting from a mutation in one of several cardiac sarcomeric proteins [...].
Identifiants
pubmed: 36975870
pii: jcdd10030106
doi: 10.3390/jcdd10030106
pmc: PMC10053221
pii:
doi:
Types de publication
Editorial
Langues
eng
Références
Lancet. 2013 Jan 19;381(9862):242-55
pubmed: 22874472
J Am Coll Cardiol. 2022 Feb 1;79(4):372-389
pubmed: 35086660
Circulation. 2021 Feb 9;143(6):606-608
pubmed: 33190524
J Am Coll Cardiol. 1991 May;17(6):1343-51
pubmed: 2016452
Xenobiotica. 2019 Jun;49(6):718-733
pubmed: 30044681
Cardiol Clin. 2019 Feb;37(1):1-10
pubmed: 30447709
Circulation. 2020 Dec 22;142(25):e533-e557
pubmed: 33215938
Lancet. 2020 Sep 12;396(10253):759-769
pubmed: 32871100
J Cardiovasc Dev Dis. 2022 May 25;9(6):
pubmed: 35735798
Circ Res. 2017 Sep 15;121(7):749-770
pubmed: 28912181
J Am Coll Cardiol. 2023 Jan 3;81(1):34-45
pubmed: 36599608
J Am Coll Cardiol. 2020 Jun 2;75(21):2649-2660
pubmed: 32466879
J Cardiovasc Dev Dis. 2022 Oct 29;9(11):
pubmed: 36354769
Ann Intern Med. 2019 Jun 4;170(11):741-748
pubmed: 31035291